Claim Window Now CLOSED

RevitaLash Class Action Lawsuit

Updated
RevitaLash and RevitaBrow were allegedly marketed as safe “cosmetics” while failing to disclose serious eye-related risks linked to a prostaglandin ingredient.
See settlements you can still claim

Chimo is a private monitoring and filing service and is not the court, the settlement administrator or a law firm.

Mascara wand next to long eyelashes – RevitaLash eye serum class action

What happens next with the RevitaLash settlement

The claim deadline passed on April 16, 2026. New claims for this settlement are no longer being accepted.

Payments come after approval, and after any appeals. Anyone who objected to the settlement can ask a higher court to look at it again — an appeal — and that has to finish first. Eligible payments are sent once approval is final, and the stretch from a claim deadline to money in hand often runs a year or more. It varies from one settlement to the next.

Filed this claim with Chimo? The status of your claim is on the claims page in your account.

2026 Class Action Settlements > RevitaLash Class Action

RevitaLash Class Action Lawsuit

Doriann Slattery sued Athena Cosmetics, Inc. in the U.S. District Court for the Central District of California in November 2023, saying that its RevitaLash and RevitaBrow eye serums were marketed as safe cosmetics without adequately disclosing potential eye-related risks tied to a prostaglandin analog ingredient. Athena denies the claims and says the products are safe, and the court did not decide who was right.

The RevitaLash Eye Serum class action case, including Doriann Slattery v. Athena Cosmetics, Inc., Case No. 2:23-cv-10078, and Rebecca Rush v. Athena Cosmetics, Inc., Case No. 2:24-cv-08542-HDV-AJR, is before Judge Hernán D. Vera. The lawsuits began in 2023 and 2024 and were consolidated in November 2024, alongside a parallel case Corrine Markoff filed in the Northern District of Illinois.

Plaintiffs Doriann Slattery, Rebecca Rush, and Corrine Markoff—represented by Honik LLC, Farnese P.C., and Lou Law—alleged violations of state consumer protection statutes, fraud, negligent misrepresentation, breach of warranty, negligence, and unjust enrichment. The RevitaLash Eye Serum legal claims focus on alleged omissions and misleading safety representations.

The case reached a settlement in 2025 establishing a $3.036 million cash fund and a $1.134 million voucher fund.

Lawsuit Name
Slattery v. Athena Cosmetics, Inc. (lead case, consolidated with Rush v. Athena Cosmetics, Inc.)
Court
U.S. District Court, Central District of California
Case Number
2:23-cv-10078-HDV-AJR (lead); Rush: 2:24-cv-08542-HDV-AJR
Judge
Judge Hernán D. Vera
Plaintiffs
Rebecca Rush; Corrine Markoff
Defendants
Athena Cosmetics, Inc.
Key Allegation
Alleges that Athena's marketing and labels didn’t disclose risks and side effects tied to an ingredient in RevitaLash and RevitaBrow serums.

RevitaLash Class Action Settlement - $4,170,000

The settlement agreement, signed November 11, 2025, sets a $4,170,000 total resolution in the consolidated lawsuits against Athena Cosmetics, Inc. The RevitaLash Eye Serum lawsuit settlement amount includes a $3,036,000 non-reversionary cash fund and a $1,134,000 voucher fund. The $4.17 million RevitaLash settlement total wasn’t a fine or penalty—it was the result of a negotiated compromise. As part of that settlement, Athena agreed to implement specific label changes, update website disclosures, and maintain those changes for at least two years.

The settlement covers consumers in the United States who purchased RevitaLash Advanced, RevitaLash Advanced Sensitive, RevitaLash Advanced Pro, or RevitaBrow Advanced between January 1, 2017, and December 29, 2025, the date the court entered its preliminary approval order. This defines RevitaLash Eye Serum settlement eligibility.

Under the agreement, eligible class members could receive a pro rata cash payment, with additional amounts available for documented purchases, or elect a $110 product voucher.

Claims closed: April 16, 2026

Eye Serum Class Action Payout: $110 Voucher or Cash Share

The claim deadline for the RevitaLash Eye Serum settlement was April 20, 2026. New claims can no longer be filed. A final approval hearing was scheduled for May 21, 2026. Under the settlement, payments are made to eligible claimants within 21 days after final approval and any appeals.
​
The settlement included a $3,036,000 non-reversionary cash fund and a $1,134,000 voucher fund. Cash was to be split pro rata after attorneys' fees, administration costs, and service payments. Claimants who appeared in Athena's records or had proof of purchase were eligible for a payment for each product claimed, and claimants without proof were limited to one cash payment per household. The notice gave no per-product estimate, because the amount depended on how many valid claims were filed.
​
A claimant could elect a $110 product voucher instead of cash, limited to one per household without proof of purchase. Claimants with proof of purchase could elect both a single cash payment and a single voucher. Vouchers are non-expiring, transferable, and can be combined with other discount codes and promotions.
​
Any unclaimed cash and vouchers go to City of Hope, not back to the company.

False Advertising Class Action Payouts

Rodan + Fields Lash Boost Class Action. Failure to disclose prostaglandin-related side effects (similar theory). Settlement: $38 million
$175
RapidLash / NeuLash FDA-related litigation. Prostaglandin analog in cosmetic products without proper disclosure.
$100
Allergan – Latisse Marketing Litigation Misrepresentation related to eyelash growth products
$80.00
Average Payouts

Eye Serum Class Action Eligibility

The RevitaLash eligibility rules were built around proof and records. Claimants who appeared in Athena’s internal purchase records could qualify for per-product recovery even without uploading receipts, while those without proof were limited to one benefit per household. The class was also limited to purchases made for “personal, family, or household purposes,” which left out resellers. Excluded were anyone with pending litigation against Athena, Athena's current officers, directors, and shareholders, Athena's legal counsel and their employees, government entities, and the judicial officers presiding over the case, with their families and staff.

You purchased RevitaLash Advanced, RevitaLash Advanced Sensitive, RevitaLash Advanced Pro, or RevitaBrow Advanced.
You made your purchase in the U.S. between January 1, 2017, and December 29, 2025.

FAQ

The RevitaLash Eye Serum class action lawsuit alleges that Athena Cosmetics failed to disclose potential risks linked to a prostaglandin analog ingredient in certain lash and brow serums.

Consumers who purchased qualifying RevitaLash or RevitaBrow products in the United States between January 1, 2017, and December 29, 2025, could qualify.

The total RevitaLash Eye Serum settlement is $4,170,000, including a cash fund and a voucher fund.

The notice gave no per-bottle figure. Cash was to be split pro rata from the $3,036,000 cash fund after fees and costs, with a payment per product for claimants in Athena's records or with proof of purchase, and one payment per household otherwise.

Covered products include RevitaLash Advanced, RevitaLash Advanced Sensitive, RevitaLash Advanced Pro, and RevitaBrow Advanced.

The lawsuits alleged violations of state consumer protection laws, fraud, negligent misrepresentation, breach of express and implied warranty, negligence, and unjust enrichment. Athena denies the claims.

Proof of purchase was not required for one household claim, but it allowed claimants to recover for multiple units.

Sources

These are the court's own records for this case. They are hosted here unchanged, so you can check anything on this page against the documents themselves.

The full case file is on the court docket: view the docket.

CHIMO
Sign up for updates on new lawsuits
and unclaimed money opportunities
© 2026 Chimo AI Inc. - All rights reserved.

Chimo AI Inc. is a private company. We are not a law firm, do not give legal advice, and are not affiliated with or endorsed by any court, settlement administrator, defendant or government agency.

About Us Contact Us Privacy Policy Terms and Conditions